These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5626572)

  • 41. [Treatment of threatened abortion with dydrogesterone].
    Ehrenskjöld ML; Bondo B; Weile F
    Ugeskr Laeger; 1967 Dec; 129(50):1678-9. PubMed ID: 5889245
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 43. [Action of Ercevit P on resorption of retinal hemorrhages].
    Biard L
    J Med Lyon; 1972 Dec; 53(238):1681-6. PubMed ID: 4196542
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effectiveness of oxyprogesterone-capronate in threatened abortion].
    Pashchenko AG
    Vopr Okhr Materin Det; 1968 Apr; 13(4):59-63. PubMed ID: 5703209
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of vein-active drugs on venous obstruction edema or post-thrombotic syndrome].
    Fischer H
    Arzneimittelforschung; 1969 Mar; 19(3):298-300. PubMed ID: 5818775
    [No Abstract]   [Full Text] [Related]  

  • 46. [The effects of the combined use of mineral water with ascorbic acid and rutin experimentally and clinically].
    Polushina ND; Kartazaeva VA; Botvineva LA; Kozhevnikov SA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2000; (2):31-4. PubMed ID: 11094893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Isoxsuprine as a uterine muscle relaxant. I. In threatened abortion].
    Cucinella N; Di Grigoli D; Giambanco V
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1511-5. PubMed ID: 5745194
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hormone therapy in threatened abortion. Retrospective evaluation of a clinical caseload].
    Revelli E; Patriarca A; Gilli V
    Minerva Ginecol; 1982 Apr; 34(4):277-82. PubMed ID: 7099479
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effects of isoxsuprine hydrochloride in threatened abortion].
    Cazzola D
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):382-96. PubMed ID: 5628977
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vitamin P in the nutrition of athletes].
    Borisov IM
    Vopr Pitan; 1980; (1):35-8. PubMed ID: 7376551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the use of a delayed-action progestational hormone in threatened abortion].
    Candotti G; Scillieri P
    Minerva Ginecol; 1968 Jul; 20(13):1147-51. PubMed ID: 5706588
    [No Abstract]   [Full Text] [Related]  

  • 52. [Semiologic importance of meno-metrorrhagia in women under long term anticoagulant therapy].
    Mathieu J; Dargent D; Moine C
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(3):282-4. PubMed ID: 5713265
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of acute respiratory infections among service-men].
    Zaĭtsev AA; Tropin AV; Lukashin RV; Iatsuk VR; Sedykh IuP; Klochkov OI
    Voen Med Zh; 2007 Nov; 328(11):15-9. PubMed ID: 18306707
    [No Abstract]   [Full Text] [Related]  

  • 54. [JUVENILE FUNCTIONAL METRORRHAGIAS].
    USANDIZAGA JA
    Acta Gynaecol Obstet Hisp Lusit; 1963; 12():113-54. PubMed ID: 14042445
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long term treatment with delayed strong solurutine papaverine].
    Vincendeau MJ
    Bord Med; 1971 Nov; 4(11):3347-50. PubMed ID: 5002837
    [No Abstract]   [Full Text] [Related]  

  • 56. [FACTORS INCREASING CAPILLARY RESISTANCE. RUTOSIDE AND SOME OF ITS DERIVATIVES COMPARED WITH CATECHIN].
    PARROT JL; CANU P
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():234-48. PubMed ID: 14248349
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic effectiveness of rimantadine and antigrippen against A1(H1N1) influenza in the 1977-1978 epidemic].
    Zlydnikov DM; Romanov IuA; Rumel' NB; Vasilevskaia NM; Geĭker VI
    Vrach Delo; 1981 Jun; (6):109-11. PubMed ID: 7257284
    [No Abstract]   [Full Text] [Related]  

  • 58. [Role of progesterone in the 1st trimester of pregnancy and in the treatment of threatened abortion].
    Bengtsson LP
    Rev Fr Gynecol Obstet; 1968 Mar; 63(3):73-81. PubMed ID: 5761334
    [No Abstract]   [Full Text] [Related]  

  • 59. [The interest and prospects of Daflon treatment in obstetrical and gynaecological practice].
    Muller P; Wolff F; Schick RA; Szwarcberg R
    Rev Fr Gynecol Obstet; 1973 May; 68(5):345-9. PubMed ID: 17474201
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use and dosage of hormones in threatened abortion. 1952].
    Viesca B E; Iturriaga AM; Albores Culebro C
    Ginecol Obstet Mex; 2007 Aug; 75(8):488-95. PubMed ID: 18293680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.